3'-((1R)-1-((6R)-5,6-dihydro-4-hydroxy-2-oxo-6-phenethyl-6-propyl-2h-pyran-3-yl)propyl)-5-(trifluoromethyl)-2-pyridinesulfonanilide,
Aptivus,
PNU 140690,
PNU-140690,
tipranavir,
tipranavir, (R-(R*,R*))-isomer,
tipranavir, (S-(R*,R*))-isomer,
tipranavir, (S-(R*,S*))-isomer,
Tipranavir,
174484-41-4,
Aptivus,
PNU-140690,
TPV,
UNII-ZZT404XD09,
U-140690,
PNU 140690,
ZZT404XD09,
CHEBI:63628,
3'-((1R)-1-((6R)-5,6-Dihydro-4-hydroxy-2-oxo-6-phenethyl-6-propyl-2H-pyran-3-yl)propyl)-5-(trifluoromethyl)-2-pyridinesulfonanilide,
N-(3-{(1R)-1-[(6R)-4-HYDROXY-2-OXO-6-PHENETHYL-6-PROPYL-5,6-DIHYDRO-2H-PYRAN-3-YL]PROPYL}PHENYL)-5-(TRIFLUOROMETHYL)-2-PYRIDINESULFONAMIDE,
N-(3-{(1R)-1-[(6R)-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-5,6-dihydro-2H-pyran-3-yl]propyl}phenyl)-5-(trifluoromethyl)pyridine-2-sulfonamide,
N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-phenethyl-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide,
C31H33F3N2O5S,
Aptivus(TM),
2-Pyridinesulfonamide, N-[3-[(1R)-1-[(6R)-5,6-dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2H-pyran-3-yl]propyl]phenyl]-5-(trifluoromethyl)-,
Tipranavir (INN),
Aptivus (TN),
Tipranavir [INN:BAN],
Aptivus (Boehringer Ingelheim),
HSDB 8083,
NCGC00182028-01,
2-Pyridinesulfonamide, N-(3-((1R)-1-((6R)-5,6-dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2H-pyran-3-yl)propyl)phenyl)-5-(trifluoromethyl)-,
N-{3-[(1R)-1-[(6R)-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-5,6-dihydro-2H-pyran-3-yl]propyl]phenyl}-5-(trifluoromethyl)pyridine-2-sulfonamide,
U 140690,
1d4y,
2o4l,
2o4n,
2o4p,
AC1Q4JPW,
AC1L22FH,
DSSTox_CID_28548,
DSSTox_RID_82820,
DSSTox_GSID_48622,
SCHEMBL40629,
SCHEMBL40630,
CHEMBL183041,
CHEMBL222559,
DTXSID6048622,
CTK8E7540,
tipranavir(pnu-140690,aptivus),
Tox21_112962,
AKOS030254403,
ZINC100016058,
ZINC100022637,
AN-5550,
CS-1210,
DB00932,
NCGC00379087-01,
HY-15148,
RT-016034,
CAS-174484-41-4,
FT-0675248,
X2005,
D08605,
W-5247,
A811642,
J-010991,
2-Pyridinesulfonamide, N-(3-(1-(5,6-dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2H-pyran-3-yl)propyl)phenyl)-5-(trifluoromethyl)-, (R-(R*,R*))-,
N-(3-((R)-1-((R)-6-hydroxy-4-oxo-2-phenethyl-2-propyl-3,4-dihydro-2H-pyran-5-yl)propyl)phenyl)-5-(trifluoromethyl)pyridine-2-sulfonamide,
N-[3-[(1R)-1-[(2R)-4-hydroxy-6-oxo-2-phenethyl-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide,
N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)-2-pyridinesulfonamide,
N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide,
N-[3-[(1R)-1-[(2R)-6-oxidanyl-4-oxidanylidene-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide,
N-[3-[(1R)-1-[(6R)-5,6-Dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2H-pyran-3-yl]propyl]phenyl]-5-(trifluoromethyl)-2-pyridinesulfonamide,
D0EV6T,
PNU-140690E,
CID65027,
tipranavir, (R-(R*,R*))-isomer,
tipranavir, (S-(R*,R*))-isomer,
tipranavir, (S-(R*,S*))-isomer,
C31-H33-F3-N2-O5-S,
A3876,
C107201,
174590-27-3,
191150-83-1,
N-[3-[(1R)-1-[(6R)-2-Hydroxy-4-oxo-6-phenethyl-6-propyl-5H-pyran-3-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide,